Medication Adherence and Medication Management Programs


Medication Adherence Programs improve medication compliance through the provision of community pharmacy services.

Medication Management Programs support quality use of medicine services that are designed to reduce adverse medicine events and associated hospital admissions or medical presentations.

Dose Administration Aids

Dose Administration Aids (DAAs) have been designed to assist consumers in the community to better manage their medicines, with the objective of avoiding medication misadventure and improving medication compliance.

For the purpose of this program a Dose Administration Aid (DAA) is defined as a well-sealed, tamper-evident device that allows individual medicine doses to be organised according to the prescribed dose schedule.  There are a number of commercially available products on the market.

This program specifically relates to the DAA service delivery to patients living within the community and excludes patients who reside in Government funded Residential Aged Care Facilities (RACF) or correctional facilities.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/

Clinical Interventions

Clinical Interventions has been designed to identify, resolve and document drug-related issues that are identified with community pharmacy. The Program seeks to improve patient health outcomes and improve quality use of medicines.

A Clinical Intervention is a professional activity undertaken by a registered pharmacist directed towards improving quality use of medicines and resulting in a recommendation for a change in the patient’s medication therapy, means of administration or medication-taking behaviour.

It does not include generic medicine substitution, routine prescription-related counselling, provision of emergency supply medicine under State or Territory law, CMI provision or professional activities directed towards improving QUM undertaken during HMR, RMMR, MedsCheck or Diabetes MedsCheck services.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/

Staged Supply

Staged Supply has been designed to support the provision of PBS medicines in instalments when requested by the prescriber (excluding the section 100 opioid dependency treatment program). These instalments may be daily, weekly, or as otherwise agreed with the prescriber. The service is particularly targeted to patients with a mental illness, drug dependency or who are otherwise unable to manage their medicines safely.

For the purpose of this program Staged Supply is the provision of PBS medicines in instalments when requested by the prescriber. The frequency of Staged Supply dosing instalments should be determined by the prescriber in consultation with the pharmacy and patient/carer. Staged Supply services specifically exclude medicines supplied under the Section 100 Opioid Dependence Treatment Program.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/

Home Medicines Review

Home Medicines Reviews have been designed to enhance the quality use of medicines and reduce the number of adverse medicine events, by assisting consumers to better manage and understand their medicines through a medication review conducted by an accredited pharmacist in the patient’s home.

A Home Medicines Review (HMR) is a comprehensive clinical review of a patient’s medicines in their home by an accredited pharmacist on referral from the patient’s general practitioner (GP). The patient may choose to be referred to their usual community pharmacy or an accredited pharmacist who meets the patient’s needs.

The service involves cooperation between the GP, pharmacist, other health professionals and their patient (and, where appropriate, their carer).  A HMR service improves the patient’s and health professionals’ knowledge and understanding about medicines, facilitates cooperative working relationships between members of the health care team in the interests of patient health and wellbeing and provides medication information to the patient and other health care providers involved in the patient’s care.

Promotional resources for this program are available here.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/

MedsCheck and Diabetes MedsCheck

Medscheck and Diabetes Medscheck has been designed to provide an in-pharmacy medicine review between pharmacists and consumers to enhance quality use of medicines and reduce the number of adverse medicines events.

For the purpose of the program a MedsCheck is an in-pharmacy, patient-centred service that includes a review of a patient’s medicines, focusing on education and self-management and aims to identify problems that the patient may be experiencing with their medicines; help the patient learn more about their medicines including how medicines affect medical conditions; improve the effective use of medicines by patients; and educate patients about how to best use and store their medicines.

For the purpose of the program a Diabetes MedsCheck is an in-pharmacy, patient-centred service that provides a review of medications with a focus on the patient’s type 2 diabetes medicines management, monitoring devices, education and self-management. This service is targeted at patients who are unable to gain timely access to other diabetes education or health services in their community and aims to optimise a patient’s effective use of medicine through improving understanding of, and compliance with, their diabetes medication therapy; improve a patient’s effective use of blood glucose monitoring devices through training and education; improve blood glucose control; and reduce the risk of the patient developing complications associated with type 2 diabetes.

Promotional resources for this program are available here.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/

Residential Medication Management Review and QUM

Residential Medication Management Reviews have been designed to enhance the quality use of medicines for consumers in approved Australian Government funded aged care facilities, by assisting consumers and their carers to better manage their medicines. The program will also support activities that are designed to improve quality use of medicines across approved Australian Government funded aged care facilities through the QUM component of the program.

A Residential Medication Management Review (RMMR) is a service provided to a permanent resident of an Australian Government funded aged care facility. It is conducted by an accredited pharmacist when requested by a resident’s general practitioner (GP) and undertaken in collaboration with the resident’s GP and appropriate members of the resident’s healthcare team. A comprehensive assessment is undertaken to identify, resolve and prevent medication-related problems and is provided to the resident’s GP.

Residents in flexible care arrangements and transitional care facilities are also eligible for RMMRs.

The QUM service is a separate service provided by a registered or accredited pharmacist and focuses on improving practices and procedures as they relate to the quality use of medicines in a residential care facility.

From 1 February 2019 claiming under this program is to be completed via the Pharmacy Programs Administrator Registration and Claiming Portal, accessible at: https://www.ppaonline.com.au/